Fundraising Fox

AGH Therapeutics

Nashville, US · Founded 2014 · Tennessee corporation

Biotech

Founders & leadership

MA
Matthew A GondaExecutive

Board

RP
Raymond PirtleBoard director
TG
Thomas G AndrewsBoard director
JM
Jerry M KluftBoard director
LG
Lawrence GreerBoard director

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 3 of 4 rounds · 2015–2023

▶$725KraisedJan 2024 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew GondaDirector
  • Lawrence GreerDirector
  • Satish JoshiDirector
  • Michael HowellDirector
  • Dennis CarloDirector
  • Raymond PirtleDirector
Offering amount
$6M
Amount sold
$725K
Minimum investment
$50K
First sale
Dec 2023
Incorporated
Corporation, Tennessee
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedAug 2020 · 34 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel PirtleDirector
  • Thomas AndrewsDirector
  • Daniel CanaleDirector
  • Dennis CarloDirector
  • Larry GreerDirector
  • Matthew GondaExecutive Officer, Director
Offering amount
$12M
Amount sold
$3.6M
Minimum investment
$25K
Proceeds to insiders
$383.1K
First sale
Jan 2020
Incorporated
Corporation, Tennessee, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MofferedSep 2017 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis J CarloDirector
  • Lawrence W GreerDirector
  • Raymond PirtleDirector
  • Matthew A GondaExecutive Officer, Director
  • Thomas G AndrewsDirector
Offering amount
$2.1M
Minimum investment
$25K
First sale
Jul 2017
Incorporated
Corporation, Tennessee, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedJul 2016 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew A GondaExecutive Officer, Director
  • Raymond PirtleDirector
  • Thomas G AndrewsDirector
  • Jerry M KluftDirector
  • Lawrence GreerDirector
Offering amount
$4.5M
Amount sold
$600K
Minimum investment
$25K
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has AGH Therapeutics raised?
AGH Therapeutics has disclosed $4.9M raised across 3 of its 4 known rounds.
Where is AGH Therapeutics headquartered?
AGH Therapeutics is headquartered in Nashville, US.